Circulating miR-146a expression as a non-invasive predictive biomarker for acute lymphoblastic leukemia

Abstract Dysregulation of non-coding microRNAs during the course of tumor development, invasion and/or progression to the distant organs, makes them a promising candidate marker for the diagnosis of cancer and associated malignancies. This exploratory study aims at evaluating the usefulness of plasm...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Samiah Shahid, Wajeehah Shahid, Jawaria Shaheen, M. Waheed Akhtar, Saima Sadaf
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3151dd48426a45ab8b9d62c773b90e29
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3151dd48426a45ab8b9d62c773b90e29
record_format dspace
spelling oai:doaj.org-article:3151dd48426a45ab8b9d62c773b90e292021-11-28T12:17:20ZCirculating miR-146a expression as a non-invasive predictive biomarker for acute lymphoblastic leukemia10.1038/s41598-021-02257-42045-2322https://doaj.org/article/3151dd48426a45ab8b9d62c773b90e292021-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-02257-4https://doaj.org/toc/2045-2322Abstract Dysregulation of non-coding microRNAs during the course of tumor development, invasion and/or progression to the distant organs, makes them a promising candidate marker for the diagnosis of cancer and associated malignancies. This exploratory study aims at evaluating the usefulness of plasma concentration of circulating mir-146a as a non-invasive biomarker for acute lymphoblastic leukemia (ALL). Total RNA including miRNA was isolated from 110 plasma samples of patients (n = 66), healthy controls (n = 24) and follow up (n = 20) cases and reverse transcribed. Relative concentrations were assessed using real-time quantitative PCR and fold-change was calculated by 2−ΔΔCt method. Finally, relative concentrations were correlated to clinicopathological factors. Patients (n = 66) were analyzed to determine fold expression of miR-146a in plasma samples of ALL. Before chemotherapy, pediatric (n = 42) and adult (n = 24) showed overexpression of miR-146a compared with healthy controls (P < 0.0001). There was no effect of age and gender on mir-146a expression in plasma. mirR-146a expression was independent of clinical and hematological features. Moreover, miR-146a levels in plasma of paired samples (n = 20) after treatment showed significant decrease in expression (P < 0.001). Expression of plasma miR-146a may be utilized as non-invasive marker to diagnose and predict prognosis in pediatric and adult patients with ALL. Moreover predicted targets may be utilized for ALL therapy in future.Samiah ShahidWajeehah ShahidJawaria ShaheenM. Waheed AkhtarSaima SadafNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Samiah Shahid
Wajeehah Shahid
Jawaria Shaheen
M. Waheed Akhtar
Saima Sadaf
Circulating miR-146a expression as a non-invasive predictive biomarker for acute lymphoblastic leukemia
description Abstract Dysregulation of non-coding microRNAs during the course of tumor development, invasion and/or progression to the distant organs, makes them a promising candidate marker for the diagnosis of cancer and associated malignancies. This exploratory study aims at evaluating the usefulness of plasma concentration of circulating mir-146a as a non-invasive biomarker for acute lymphoblastic leukemia (ALL). Total RNA including miRNA was isolated from 110 plasma samples of patients (n = 66), healthy controls (n = 24) and follow up (n = 20) cases and reverse transcribed. Relative concentrations were assessed using real-time quantitative PCR and fold-change was calculated by 2−ΔΔCt method. Finally, relative concentrations were correlated to clinicopathological factors. Patients (n = 66) were analyzed to determine fold expression of miR-146a in plasma samples of ALL. Before chemotherapy, pediatric (n = 42) and adult (n = 24) showed overexpression of miR-146a compared with healthy controls (P < 0.0001). There was no effect of age and gender on mir-146a expression in plasma. mirR-146a expression was independent of clinical and hematological features. Moreover, miR-146a levels in plasma of paired samples (n = 20) after treatment showed significant decrease in expression (P < 0.001). Expression of plasma miR-146a may be utilized as non-invasive marker to diagnose and predict prognosis in pediatric and adult patients with ALL. Moreover predicted targets may be utilized for ALL therapy in future.
format article
author Samiah Shahid
Wajeehah Shahid
Jawaria Shaheen
M. Waheed Akhtar
Saima Sadaf
author_facet Samiah Shahid
Wajeehah Shahid
Jawaria Shaheen
M. Waheed Akhtar
Saima Sadaf
author_sort Samiah Shahid
title Circulating miR-146a expression as a non-invasive predictive biomarker for acute lymphoblastic leukemia
title_short Circulating miR-146a expression as a non-invasive predictive biomarker for acute lymphoblastic leukemia
title_full Circulating miR-146a expression as a non-invasive predictive biomarker for acute lymphoblastic leukemia
title_fullStr Circulating miR-146a expression as a non-invasive predictive biomarker for acute lymphoblastic leukemia
title_full_unstemmed Circulating miR-146a expression as a non-invasive predictive biomarker for acute lymphoblastic leukemia
title_sort circulating mir-146a expression as a non-invasive predictive biomarker for acute lymphoblastic leukemia
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/3151dd48426a45ab8b9d62c773b90e29
work_keys_str_mv AT samiahshahid circulatingmir146aexpressionasanoninvasivepredictivebiomarkerforacutelymphoblasticleukemia
AT wajeehahshahid circulatingmir146aexpressionasanoninvasivepredictivebiomarkerforacutelymphoblasticleukemia
AT jawariashaheen circulatingmir146aexpressionasanoninvasivepredictivebiomarkerforacutelymphoblasticleukemia
AT mwaheedakhtar circulatingmir146aexpressionasanoninvasivepredictivebiomarkerforacutelymphoblasticleukemia
AT saimasadaf circulatingmir146aexpressionasanoninvasivepredictivebiomarkerforacutelymphoblasticleukemia
_version_ 1718408068311547904